MD Anderson Research Highlights for March 12, 2025
Peer-Reviewed Publication
Updates every hour. Last Updated: 4-Sep-2025 17:11 ET (4-Sep-2025 21:11 GMT/UTC)
Large, undisturbed forests are better for harboring biodiversity than fragmented landscapes, according to University of Michigan research.
Ecologists agree that habitat loss and the fragmentation of forests reduces biodiversity in the remaining fragments. But ecologists don't agree whether it's better to focus on preserving many smaller, fragmented tracts of land or larger, continuous landscapes. The study, published in Nature and led by U-M ecologist Thiago Gonçalves-Souza, comes to a conclusion on the decades-long debate.
"Fragmentation is bad," said study author Nate Sanders, U-M professor of ecology and evolutionary biology. "This paper clearly shows that fragmentation has negative effects on biodiversity across scales. That doesn't mean we shouldn't try to conserve small fragments when we can with our limited conservation dollars, but we need to be wise about conservation decisions."IPHES-CERCA leads a study published in Nature on ‘Pink,’ a facial fragment discovered in Sima del Elefante.
This fossil has been assigned to Homo aff. erectus, a different and more primitive species than Homo antecessor.
This study confirms that Western Europe was inhabited by at least two different species of hominins during the Early Pleistocene.
In developing hearts, cells shuffle around, bumping into each other to find their place, and the stakes are high: pairing with the wrong cell could mean the difference between a beating heart and one that falters. A study publishing on March 12 in the Cell Press journal Biophysical Journal demonstrates how heart cells go about this “matchmaking” process. The researchers model the intricate movements of these cells and predict how genetic variations could disrupt the heart development process in fruit flies.
Researchers from the University of Colorado Anschutz Medical Campus studied a new method to deliver antibiotics, specifically gentamicin, directly into the bladder tissue to better treat UTIs. They did this by creating nanogels combined with a special peptide (a small protein) that helps the drug get inside the cells where the bacteria are hiding.
The results, published in Nanomedicine, demonstrate that this approach proved highly effective when tested in animal models with UTIs, eliminating over 90% of the bacteria from the bladder.
“We prove not only that this technology is doable but could be very effective for future clinical use and can potentially lead towards an eventual cure of recurrent infections,” said the paper’s senior author Michael Schurr, PhD, associate professor in the Department of Immunology & Microbiology at the University of Colorado School of Medicine.
The researchers discovered that nanogel technology can carry more than enough gentamicin to be effective - about 36% more gentamicin inside cells compared to standard antibiotic delivery methods. Additionally, it exhibits low toxicity, causing minimal harm to cells.
They also found that nanogels release the drug quickly, which helps kill bacteria in the bladder faster.